ADP:NASDAQAutomatic Data Processing, Inc. Analysis
Data as of 2026-06-09 - not real-time
$229.55
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
ADP is trading at $229.55, comfortably above its 20‑day SMA ($222.35) and 50‑day SMA ($211.00) while still below the 200‑day SMA ($245.80), indicating a neutral‑to‑bullish short‑term bias. Technicals are supportive – the MACD is bullish (line above signal) and the RSI sits at 60, suggesting room for further upside without immediate overbought pressure. Fundamentally, the stock appears modestly overvalued against its DCF fair value of $206, yet its forward PE of 18.8 is well below the industry average of 35.5, and a 7.5% upside/downside estimate aligns with the current price. Cash generation is strong: operating cash flow exceeds $5.4 B and free cash flow $4.7 B, supporting a 2.97% dividend yield with a 60% payout ratio, making the dividend sustainable.
Looking ahead, ADP’s 7% revenue growth, 48% gross margin, and an exceptional ROE of 71% underscore a high‑quality, cash‑rich business poised to benefit from AI‑driven HCM solutions. However, volatility remains elevated (~37% 30‑day) and volume trends are decreasing, which tempers the risk profile. Overall, the company offers a blend of growth and value characteristics with a solid dividend, making it attractive for investors with a medium‑to‑long‑term horizon.
Looking ahead, ADP’s 7% revenue growth, 48% gross margin, and an exceptional ROE of 71% underscore a high‑quality, cash‑rich business poised to benefit from AI‑driven HCM solutions. However, volatility remains elevated (~37% 30‑day) and volume trends are decreasing, which tempers the risk profile. Overall, the company offers a blend of growth and value characteristics with a solid dividend, making it attractive for investors with a medium‑to‑long‑term horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and RSI below overbought levels
- Price above short‑term moving averages
- Strong dividend yield with sustainable payout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests ~7% upside
- Robust cash flow and low forward PE vs industry
- Continued revenue growth and high operating margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High ROE and durable recurring revenue model
- Strategic AI‑driven HCM initiatives
- Dividend king status with consistent yield
Key Metrics & Analysis
Financial Health
Revenue Growth7.00%
Profit Margin20.12%
P/E Ratio21.4
ROE71.21%
ROA5.95%
Debt/Equity69.26
P/B Ratio14.5
Op. Cash Flow$5.5B
Free Cash Flow$4.7B
Industry P/E35.5
Technical Analysis
TrendNeutral
RSI60.6
Support$204.56
Resistance$237.11
MA 20$222.35
MA 50$211.00
MA 200$245.80
MACDBullish
VolumeDecreasing
Fear & Greed Index85.2
Valuation
Fair Value$206.01
Target Price$246.80
Upside/Downside7.51%
GradeOvervalued
TypeBlend
Dividend Yield2.97%
Risk Assessment
Beta0.27
Volatility36.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.